![Pantoprazole Related Compound B pharmaceutical secondary standard, certified reference material | 102625-64-9 Pantoprazole Related Compound B pharmaceutical secondary standard, certified reference material | 102625-64-9](https://www.sigmaaldrich.cn/deepweb/assets/sigmaaldrich/product/structures/196/482/d2954f3c-ae10-49f9-bca3-0213382d25e7/640/d2954f3c-ae10-49f9-bca3-0213382d25e7.png)
Pantoprazole Related Compound B pharmaceutical secondary standard, certified reference material | 102625-64-9
![Environmentally Benign and Facile Process for the Synthesis of Pantoprazole Sodium Sesquihydrate: Phase Transformation of Pantoprazole Sodium Heterosolvate to Pantoprazole Sodium Sesquihydrate | ACS Omega Environmentally Benign and Facile Process for the Synthesis of Pantoprazole Sodium Sesquihydrate: Phase Transformation of Pantoprazole Sodium Heterosolvate to Pantoprazole Sodium Sesquihydrate | ACS Omega](https://pubs.acs.org/cms/10.1021/acsomega.7b00743/asset/images/medium/ao-2017-00743m_0008.gif)
Environmentally Benign and Facile Process for the Synthesis of Pantoprazole Sodium Sesquihydrate: Phase Transformation of Pantoprazole Sodium Heterosolvate to Pantoprazole Sodium Sesquihydrate | ACS Omega
![Pantoprazole EP Impurity B|CAS.No-102625-64-9|Pantoprazole EP Impurity B, Pantoprazole USP Related Compound B|Impurity Standards, Metabolites Pantoprazole EP Impurity B|CAS.No-102625-64-9|Pantoprazole EP Impurity B, Pantoprazole USP Related Compound B|Impurity Standards, Metabolites](https://www.simsonpharma.com/admin/uploads/products/P020002.jpg)
Pantoprazole EP Impurity B|CAS.No-102625-64-9|Pantoprazole EP Impurity B, Pantoprazole USP Related Compound B|Impurity Standards, Metabolites
![Formulation and Evaluation of Pantoprazole Sodium EC Tablets: Pantoprazole Sodium Delayed Release Tablets: Unnisa Begum, Rahmath: 9783330038776: Amazon.com: Books Formulation and Evaluation of Pantoprazole Sodium EC Tablets: Pantoprazole Sodium Delayed Release Tablets: Unnisa Begum, Rahmath: 9783330038776: Amazon.com: Books](https://m.media-amazon.com/images/I/81JE8QSJQ6L._AC_UF1000,1000_QL80_.jpg)
Formulation and Evaluation of Pantoprazole Sodium EC Tablets: Pantoprazole Sodium Delayed Release Tablets: Unnisa Begum, Rahmath: 9783330038776: Amazon.com: Books
![Crystal structure of pantoprazole sodium sesquihydrate Form I, C16H14F2N3O4SNa(H2O)1.5 | Powder Diffraction | Cambridge Core Crystal structure of pantoprazole sodium sesquihydrate Form I, C16H14F2N3O4SNa(H2O)1.5 | Powder Diffraction | Cambridge Core](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary:20200327015514651-0456:S0885715620000019:S0885715620000019_fig7.png?pub-status=live)
Crystal structure of pantoprazole sodium sesquihydrate Form I, C16H14F2N3O4SNa(H2O)1.5 | Powder Diffraction | Cambridge Core
![IJMS | Free Full-Text | Proton Pump Inhibitor Pantoprazole Modulates Intestinal Microbiota and Induces TLR4 Signaling and Fibrosis in Mouse Liver IJMS | Free Full-Text | Proton Pump Inhibitor Pantoprazole Modulates Intestinal Microbiota and Induces TLR4 Signaling and Fibrosis in Mouse Liver](https://www.mdpi.com/ijms/ijms-23-13766/article_deploy/html/images/ijms-23-13766-g001.png)
IJMS | Free Full-Text | Proton Pump Inhibitor Pantoprazole Modulates Intestinal Microbiota and Induces TLR4 Signaling and Fibrosis in Mouse Liver
![Environmentally Benign and Facile Process for the Synthesis of Pantoprazole Sodium Sesquihydrate: Phase Transformation of Pantoprazole Sodium Heterosolvate to Pantoprazole Sodium Sesquihydrate | ACS Omega Environmentally Benign and Facile Process for the Synthesis of Pantoprazole Sodium Sesquihydrate: Phase Transformation of Pantoprazole Sodium Heterosolvate to Pantoprazole Sodium Sesquihydrate | ACS Omega](https://pubs.acs.org/cms/10.1021/acsomega.7b00743/asset/images/medium/ao-2017-00743m_0002.gif)
Environmentally Benign and Facile Process for the Synthesis of Pantoprazole Sodium Sesquihydrate: Phase Transformation of Pantoprazole Sodium Heterosolvate to Pantoprazole Sodium Sesquihydrate | ACS Omega
![Separations | Free Full-Text | Simultaneous Pharmacokinetic Evaluation of Pantoprazole and Vitamin B Complex for Assessing Drug–Drug Interactions in Healthy Bangladeshi Adults by a Newly Developed and Validated HPLC Method Separations | Free Full-Text | Simultaneous Pharmacokinetic Evaluation of Pantoprazole and Vitamin B Complex for Assessing Drug–Drug Interactions in Healthy Bangladeshi Adults by a Newly Developed and Validated HPLC Method](https://pub.mdpi-res.com/separations/separations-10-00170/article_deploy/html/images/separations-10-00170-ag.png?1677750180)
Separations | Free Full-Text | Simultaneous Pharmacokinetic Evaluation of Pantoprazole and Vitamin B Complex for Assessing Drug–Drug Interactions in Healthy Bangladeshi Adults by a Newly Developed and Validated HPLC Method
![102625-64-9 | Pantoprazole Sulfide | 5-(Difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]thio]-1H-benzimidazole; Pantoprazole Thioether; Pantoprazole EP Impurity B; | C₁₆H₁₅F₂N₃O₃S | TRC 102625-64-9 | Pantoprazole Sulfide | 5-(Difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]thio]-1H-benzimidazole; Pantoprazole Thioether; Pantoprazole EP Impurity B; | C₁₆H₁₅F₂N₃O₃S | TRC](https://www.trc-canada.com/prod-img/P183020.png)